Pieris teams with Strides Arcolab to develop Anticalin-based drugs
Pieris has selected Stelis Biopharma to develop and manufacture its proprietary Anticalin-based protein therapeutics.
Pieris has selected Stelis Biopharma to develop and manufacture its proprietary Anticalin-based protein therapeutics.